Home / PPLPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPLPHARMA.NS make money? Does PPLPHARMA.NS have pricing power? What's the Earnings Whisper? Will PPLPHARMA.NS profit more as the business scales? What is PPLPHARMA.NS's management track record? Is PPLPHARMA.NS's current price justified?

Piramal Pharma Limited

₹197.73 +$27.85 (+16.39%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹194.43

Day Range

₹193.6₹198.75

Year Range

₹132.3₹231.93

Market Cap

262B

AVG Volume

6.41M

Trailing/Forward PE

-83.43/52.43

PEG ratio

0.35

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

PPLPHARMA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	88.69B
2025	90.61B
2024	81.06B
2023	70.32B
2022	31.29B

Net Income (INR) · A

PPLPHARMA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	-3.26B
2025	911.3M
2024	178.2M
2023	-1.86B
2022	3.75B

Operating Income (INR) · A

PPLPHARMA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	903.9M
2025	6.79B
2024	4.32B
2023	-479.7M
2022	3.65B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Piramal Pharma Limited

Video analysis: PPLPHARMA.NS

News: PPLPHARMA.NS

Similar companies